Department of Neurology, Vanderbilt Stroke Center, A-0118 Medical Center North, Nashville, TN 37232-2551, USA.
Stroke. 2010 Jun;41(6):1175-9. doi: 10.1161/STROKEAHA.109.574129. Epub 2010 Apr 15.
Patients undergoing intra-arterial therapy (IAT) for acute ischemic stroke receive either general anesthesia (GA) or conscious sedation. GA may delay time to treatment, whereas conscious sedation may result in patient movement and compromise the safety of the procedure. We sought to determine whether there were differences in safety and outcomes in GA patients before initiation of IAT.
A cohort of 980 patients at 12 stroke centers underwent IAT for acute stroke between 2005 and 2009. Only patients with anterior circulation strokes due to large-vessel occlusion were included in the study. A binary logistic-regression model was used to determine independent predictors of good outcome and death.
The mean age was 66+/-15 years and median National Institutes of Health Stroke Scale score was 17 (interquartile range, 13-20). The overall recanalization rate was 68% and the symptomatic hemorrhage rate was 9.2%. GA was used in 44% of patients with no differences in intracranial hemorrhage rates when compared with the conscious sedation group. The use of GA was associated with poorer neurologic outcome at 90 days (odds ratio=2.33; 95% CI, 1.63-3.44; P<0.0001) and higher mortality (odds ratio=1.68; 95% CI, 1.23-2.30; P<0.0001) compared with conscious sedation.
Patients placed under GA during IAT for anterior circulation stroke appear to have a higher chance of poor neurologic outcome and mortality. There do not appear to be differences in hemorrhagic complications between the 2 groups. Future clinical trials with IAT can help elucidate the etiology of the differences in outcomes.
接受急性缺血性脑卒中动脉内治疗(IAT)的患者接受全身麻醉(GA)或清醒镇静。GA 可能会延迟治疗时间,而清醒镇静可能会导致患者移动,从而危及手术的安全性。我们旨在确定在开始 IAT 之前 GA 患者的安全性和结局是否存在差异。
在 2005 年至 2009 年间,12 个卒中中心的 980 名患者接受了急性卒中的 IAT。仅包括因大血管闭塞引起的前循环卒中患者。使用二元逻辑回归模型确定良好结局和死亡的独立预测因素。
平均年龄为 66+/-15 岁,中位数国立卫生研究院卒中量表评分为 17(四分位间距,13-20)。总体再通率为 68%,症状性出血率为 9.2%。44%的患者使用 GA,与清醒镇静组相比,颅内出血率无差异。GA 的使用与 90 天时较差的神经功能结局相关(比值比=2.33;95%CI,1.63-3.44;P<0.0001)和更高的死亡率(比值比=1.68;95%CI,1.23-2.30;P<0.0001)与清醒镇静相比。
在接受 IAT 治疗前循环卒中的患者中,接受 GA 的患者似乎更有可能出现不良神经结局和死亡率。两组之间似乎没有出血并发症的差异。未来的 IAT 临床试验可以帮助阐明结局差异的病因。